Last Update: 08/04/2006 Printer Friendly Printer Friendly   Email This Page Email This Page  

All News releases related to Preterm Labor/Birth
Your search for: All Related News Releases All Years returned the following 45 results:
09/11/08   Public Comment: DRAFT Pregnancy and Perinatology (PP) Branch Report to Council
Each component of the NICHD reports its activities to the National Advisory Child Health and Human Development (NACHHD) Council, the federal advisory committee for the NICHD. The NACHHD Council follows all regulations set forth in the Federal Advisory Committee Act.
08/27/08   Common Treatment to Delay Labor Decreases Preterm Infants' Risk for Cerebral Palsy
Preterm infants born to mothers receiving intravenous magnesium sulfate—a common treatment to delay labor—are less likely to develop cerebral palsy than are preterm infants whose mothers do not receive it, report researchers in a large National Institutes of Health research network.
06/19/08   Surgeon General's Conference Outlines Agenda to Prevent Preterm Birth
Experts convened by the National Institutes of Health for the Office of the Surgeon General released an agenda today for activities in the public and private sectors to reduce the nation’s rate of preterm birth. The agenda calls for a national system to better understand the occurrence of preterm birth and a national education program to help women reduce their chances of giving birth prematurely.
04/16/08   NIH Study Reveals Factors That Influence Premature Infant Survival, Disability
Based on observations of more than 4,000 infants, researchers in an NIH newborn research network have identified several factors that influence an extremely low birth weight infant’s chances for survival and disability. The findings offer new information to physicians and families considering the most appropriate treatment options for this category of infants.
03/05/08   NIH Receives Gates Foundation Grant to Investigate Role of Iron Supplements in Malaria
Do iron supplements worsen the course of malaria? Researchers aren’t sure, and the uncertainty has jeopardized efforts to treat the debilitating effects of iron deficiency in parts of the world where malaria and other infectious diseases are common.
02/06/08   Item of Interest: Extended Nevirapine Regimens Reduce HIV Transmission and Death in Breastfed Infants of HIV-infected Mothers
An extended course of the antiretroviral drug nevirapine (NVP) helps the breastfeeding babies of HIV-infected mothers remain HIV-negative and live longer, according to several new studies presented at the 15th Conference on Retroviruses and Opportunistic Infections held in Boston from February 3–6.
02/06/08   Item of Interest: The Post-Exposure Prophylaxis of Infant (PEPI)-Malawi Study Sponsored by NICHD and CDC
Questions and Answers
11/13/07   NICHD Perinatology Research Branch Chief Elected to Institute of Medicine
Roberto Romero, M.D., Chief of the NICHD Perinatology Research Branch, has been elected as a member of the Institute of Medicine (IOM) of the National Academies.
08/01/07   Progesterone Treatment Does Not Prevent Preterm Birth in Twin Pregnancy
Progesterone therapy does not reduce the chances of preterm birth in women pregnant with twins, reported researchers in a network sponsored by the National Institutes of Health.
05/23/07   Small Infants Have Greater Survival Rate in High Level Intensive Care Facilities
Very low birth weight infants are significantly more likely to survive when delivered in hospitals with high-level neonatal intensive care units that care for more than 100 such newborns annually than are those delivered in comparable facilities that provide care to fewer than 100 such children every year.
01/10/07   Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive Regimen
A woman's response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.)
12/18/06   Malaria Vaccine Prompts Victims' Immune System to Eliminate Parasite From Mosquitoes
Researchers at the National Institutes of Health have developed an experimental vaccine that could, theoretically, eliminate malaria from entire geographic regions, by eradicating the malaria parasite from an area’s mosquitoes.
12/07/06   Hormonal Contraception Does Not Appear To Increase HIV Risk
Using hormonal contraception does not appear to increase women's overall risk of infection with the AIDS virus, report the authors of a large study commissioned by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health.
10/05/06   Drug Prevents PostPartum Hemorrhage in Resource Poor Settings Advance Has Potential to Save Thousands of Lives
The drug misoprostol provides a safe, convenient, and inexpensive means to prevent postpartum hemorrhage, a major killer of women in developing countries. The study was conducted by researchers from the University of Missouri, India’s Jawaharlal Nehru Medical College, and the National Institutes of Health.
09/07/06   Molecules in Blood Foretell Development of Preeclampsia
High levels of two proteins in the blood of pregnant women appear to indicate the subsequent development of preeclampsia, a life-threatening complication of pregnancy, report a team of researchers from the National Institutes of Health and Beth Israel Deaconess Medical Center. The proteins, which interfere with the growth and function of blood vessels, also signal the development of high blood pressure during pregnancy.
Page      1   2   3   >

If you are a member of the media and have questions about an NICHD news release or research, or if you would like to schedule an interview with an NICHD scientist or grantee, please contact the Public Information and Communications Branch at 301-496-5133 or by fax at 301-496-7101.